概括
尼塞利亚淋病对西普罗夫洛克萨的耐药性在苏格兰正在增加. 这一趋势可能很快就会使得西普罗夫洛克萨不适合作为球菌感染的首要治疗方法.
科学领域:
- 微生物学 微生物学
- 抗微生物耐药性 抗微生物耐药性
- 公共卫生 公共卫生
背景情况:
- 这项研究回顾了1991年至1999年间苏格兰4415例感染的Neisseria gonorrhoeae易感性数据.
- 它侧重于西普洛克萨辛最小抑制度 (MIC) 值的变化.
研究的目的:
- 分析苏格兰尼塞利亚淋病分离体对西普罗素敏感性的趋势.
- 评估淋病治疗耐药性增加的临床影响.
主要方法:
- 在苏格兰 (1991-1999年) 的4415例感染中对尼塞利亚淋病分离物的回顾性审查.
- 确定每个隔离物的西普洛素最小抑制度 (MIC).
- 随着时间的推移,对敏感性趋势和耐药性比例的统计分析.
主要成果:
- 具有降低西普洛素敏感性 (MIC ≥0.05 mg/L) 的分离物的比例从1991年的0.5%增加到1999年的5% (p<0.001).
- 临床耐药性 (MIC ≥1 mg/L) 在1999年 (2.2%) 与之前的4年平均值 (0.9%,p=0.02) 相比显著上升.
结论:
- 在苏格兰的尼塞里亚淋病分离物中观察到西普罗夫洛克萨辛耐药性的显著增加.
- 耐药性的持续增长可能会损害西普洛素作为一线淋病治疗的实用性.
- 迫切的监测和潜在的治疗策略的重新评估是合理的.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
相关概念视频
00:57Antibiotic Selection
Overview
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...